Pharmacology, Toxicology and Pharmaceutical Science
Lung Cancer
100%
Chronic Obstructive Lung Disease
69%
Epidermal Growth Factor Receptor
69%
Non Small Cell Lung Cancer
49%
Mouse
43%
Cohort Study
35%
Emphysema
33%
Community Acquired Pneumonia
32%
Allergic Asthma
32%
Lung Adenocarcinoma
31%
Biological Marker
28%
Sphingosine 1 Phosphate
24%
Penfluridol
24%
Protein Tyrosine Kinase Inhibitor
24%
Microbiome
24%
Chemoradiation Therapy
20%
Asthma
19%
Disease Severity
18%
Phosphotransferase
18%
Ovalbumin
18%
Immunoglobulin E
18%
Infection
17%
Inflammation
17%
Dysbiosis
17%
Antiallergic
17%
Chemotherapy
16%
Malignant Neoplasm
16%
Esophageal Squamous Cell Carcinoma
16%
Repurposing
16%
Nephrotoxicity
16%
Reactive Oxygen Metabolite
16%
Lung Tuberculosis
16%
Quercetin
16%
Vaccination Policy
16%
Cytokine
16%
Uvomorulin
12%
Tumor Growth
12%
Epidermal Growth Factor Receptor Kinase Inhibitor
11%
Cancer Growth
11%
Mouth Cancer
10%
Adenosine Triphosphate
10%
Ethanol
10%
C Reactive Protein
9%
Acute Myeloid Leukemia
9%
Neoplasm
8%
Gelatinase A
8%
Mitogen Activated Protein Kinase
8%
Mortality Rate
8%
Curcumin
8%
Urokinase
8%
Medicine and Dentistry
Lung Cancer
83%
Epidermal Growth Factor Receptor
49%
Non Small Cell Lung Cancer
39%
Chronic Obstructive Pulmonary Disease
36%
Metastatic Carcinoma
29%
Chemoradiotherapy
28%
Radiation Therapy
27%
Cohort Analysis
27%
Lung Adenocarcinoma
26%
Penfluridol
24%
Esophageal Squamous Cell Carcinoma
24%
Emphysema
24%
Eosinophilic
21%
Cancer Cell
21%
Clinical Stage
18%
Programmed Cell Death
17%
Adenocarcinoma
16%
Intensity Modulated Radiation Therapy
16%
Snail
16%
Systematic Review
16%
Meta-Analysis
16%
Squamous Cell Carcinoma
16%
Quercetin
16%
Tyrosine-Kinase Inhibitor
16%
Nephrotoxicity
16%
Particular Matter 2.5
16%
Mortality Rate
15%
Disease
14%
Smoking
14%
Lung Tuberculosis
13%
Overall Survival
13%
Mesenchymal-Epithelial Transition
12%
Infection
11%
Signal Transduction
11%
Cell Death
11%
COVID-19
10%
Humoral Immunity
10%
Adenosine Triphosphate
10%
Leukocyte
10%
Disease Exacerbation
10%
Cancer Growth
10%
Respiratory Disease
10%
Neutrophil
9%
Epidermal Growth Factor Receptor Kinase Inhibitor
9%
Severe Acute Respiratory Syndrome Coronavirus 2
9%
Hazard Ratio
9%
Oral Cancer
9%
Adjuvant Chemotherapy
9%
Hippo Signaling
9%
Prognostic Factor
9%
Immunology and Microbiology
Signal Transduction
31%
Hippo Signaling
28%
Particulate Matter
26%
Blood Plasma
26%
Allergic Asthma
24%
Mouse
22%
Cadherin
20%
Asthma
19%
Blood Level
19%
Vaccination Policy
19%
Immunoglobulin E
18%
Cell Differentiation
17%
Mast Cell
16%
Antibody Response
14%
P53
13%
Forced Vital Capacity
13%
Catenin
12%
Adherens Junction
12%
Vaccine Efficacy
11%
Epidermal Growth Factor
10%
COVID-19
10%
Cell Proliferation
10%
Immunogenicity
10%
Lymphocyte
10%
Inflammatory Cytokine
9%
Seroconversion
9%
Humoral Immunity
9%
Genetic Polymorphism
9%
Cancer Cell
9%
Blood Cell Count
8%
Eosinophil
8%
Neutrophil
8%
Neutrophil Count
8%
Cell Activation
8%
Mesenchymal Stem Cell
8%
Umbilical Cord
8%
Intercellular Adhesion Molecule 1
8%
Seroprevalence
8%
Humoral Antibody
8%
DNA Polymorphism
8%
Humidity
8%
Immune System Function
8%
Contact Inhibition
8%
Heme
8%
G1 Phase Cell Cycle Checkpoint
8%
Regulatory T Cell
8%
Osteopontin
8%
Cell Expansion
8%
Caspase
8%
Forced Expiratory Volume
8%
